Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionDFAC - Dimensional U.S. Core Equity 2 ETF
Latest Disclosed Ownership254,040 shares
Latest Disclosed Value $ 7,146,145
DFAC - Dimensional U.S. Core Equity 2 ETF reports 0.92% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 29, 2026 - DFAC - Dimensional U.S. Core Equity 2 ETF filed a NPORT-P form disclosing ownership of 254,040 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $7,146,145 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 251,728 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 0.92% during the quarter. The current value of the position is $7,999,720 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-29 2026-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 254,040 2,312 0.92 7,146 16.84 0.0161
2026-03-27 2026-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 251,728 4,648 1.88 6,117 16.38 0.0147
2025-12-29 2025-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 247,080 57,725 30.49 5,255 30.14 0.0134
2025-09-25 2025-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 189,355 46,799 32.83 4,039 16.64 0.0113
2025-06-26 2025-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 142,556 -55,806 -28.13 3,463 -22.64 0.0113
2025-03-28 2025-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 198,362 -787 -0.40 4,475 3.09 0.0133
2024-12-30 2024-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 199,149 0 0.00 4,341 26.45 0.0139
2024-09-27 2024-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 199,149 0 0.00 3,433 14.55 0.0115
2024-06-26 2024-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 199,149 0 0.00 2,997 4.53 0.0114
2024-03-28 2024-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 199,149 0 0.00 2,868 16.03 0.0117
2023-12-28 2023-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 199,149 35,499 21.69 2,471 9.19 0.0121
2023-09-27 2023-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 163,650 53,776 48.94 2,263 29.39 0.0104
2023-06-26 2023-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 109,874 0 0.00 1,749 2.82 0.0093
2023-03-30 2023-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 109,874 33,332 43.55 1,702 60.32 0.0096
2022-12-27 2022-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 76,542 0 0.00 1,062 35.50 0.0069
2022-09-29 2022-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 76,542 34,303 81.21 784 143.93 0.0052
2022-06-27 2022-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 42,239 41,882 11,731.65 322 15,950.00 0.0023
2022-03-31 2022-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 357 357 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.